Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Solbiati, Monica ^a,b   Costantino, Giorgio ^a   Casazza, Giovanni ^c   Dipaola, Franca ^d   Galli, Andrea ^e   Furlan, Raffaello ^d   Montano, Nicola ^a,b   Sheldon, Robert ^f  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e AO Ospedale civile di Vimercate (Monza e Brianza)   (Italy)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; FAINTNESS; HUMAN; IMPLANTABLE CARDIAC MONITOR; INCIDENCE; INTERVENTION STUDY; MEDICAL DEVICE COMPLICATION; MORTALITY; OBSERVATIONAL METHOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; ADULT; DEVICES; ELECTROCARDIOGRAPHY; ELECTRODE IMPLANT; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYNCOPE;

ADULT; ELECTROCARDIOGRAPHY; ELECTRODES, IMPLANTED; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SYNCOPE;

EID: 84963808615     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011637.pub2     Document Type: Review

References (50)

1. Farwell DJ, Freemantle N, Sulke AN. Use of implantable loop recorders in the diagnosis and management of syncope. European Heart Journal 2004;25:1225-63.
2. Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. European Heart Journal 2006;27:351-6.
3. Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy in patients with syncope. Journal of the American College of Cardiology 2003;42:495-501.
4. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51.
5. Podoleanu C, Da Costa A, Defaye P, Taieb J, Galley D, Bru P, et al. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study). Archives of Cardiovascular Diseases 2014;107:546-52.
6. Hong PS, Hunt J, Freemantle N, Sulke N. The utilisation of a remotely monitored implantable loop recorder as first line investigation in the diagnosis of syncope: The EaSyAS II. Canadian Journal of Cardiology 2011;1:S295.
7. Sulke N, Hong PSG, Hunt J, Freemantle N, Podd SJ, Fonseka M, et al. Immediate use of a remotely monitored implantable loop recorder in diagnosing unexplained syncope: The Second Eastbourne Syncope Assessment Study (EaSyAS ll). Europace 2010;12:ii7.
8. Sulke N, Sugihara C, Hong P, Patel N, Freemantle N. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial. Europace 2015;Oct 12:Epub ahead of print. [DOI: 10.1093/europace/euv228]
9. Da Costa A, Defaye P, Romeyer-Bouchard C, Roche F, Dauphinot V, Deharo JC, et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. Archives of Cardiovascular Disease 2013;106:146-54.
10. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. European Heart Journal 2006;27(9):1085-92.
11. Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 2009;11:671-87.
12. Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. European Heart Journal 2003;24(9):811-9. [DOI: 10.1016/S0195-668X(02)00827-8]
13. Costantino G, Dipaola F, Solbiati M, Bulgheroni M, Barbic F, Furlan R. Is hospital admission valuable in managing syncope? Results from the STePS study. Cardiology Journal 2014;21:606-10.
14. Costantino G, Casazza G, Reed M, Bossi I, Sun B, Del Rosso A, et al. Syncope risk stratification tools vs clinical judgment: an individual patient data meta-analysis. American Journal of Medicine 2014;127:1126.e13-25.
15. Costantino G, Sun BC, Barbic F, Bossi I, Casazza G, Dipaola F, et al. Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency department. European Heart Journal 2015;Aug 4:Epub ahead of print. [DOI: 10.1093/eurheartj/ehv378]
16. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
17. Eagle KA, Black HR, Cook EF, Goldman L. Evaluation of prognostic classifications for patients with syncope. American Journal of Medicine 1985;79(4):455-60.
18. Brignole M, Ungar A, Bartoletti A, Ponassi I, Lagi A, Mussi C, et al. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace 2006;8(8):644-50.
19. Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W. Prevalence and triggers of syncope in medical students. American Journal of Cardiology 2003;91(8):1006-8.
20. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, Van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. Journal of Cardiovascular Electrophysiology 2006;17(11):1172-6.
21. Gendelman HE, Linzer M, Gabelman M, Smoller S, Scheuer J. Syncope in a general hospital patient population. Usefulness of the radionuclide brain scan, electroencephalogram, and 24-hour Holter monitor. New York State Journal of Medicine 1983;83(11-2):1161-5.
22. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
23. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
24. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
25. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
26. Huff JS, Decker WW, Quinn JV, Perron AD, Napoli AM, Peeters S, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Annals of Emergency Medicine 2007;49(4):431-44.
27. Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS. A prospective evaluation and follow-up of patients with syncope. New England Journal of Medicine 1983;309(4):197-204.
28. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation 1999;99(3):406-10.
29. Krahn AD, Klein GJ, Skanes AC, Yee R. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing and Clinical Electrophysiology 2004;27(5):657-64.
30. Kuriachan V, Sheldon RS, Platonov M. Evidence-based treatment for vasovagal syncope. Heart Rhythm 2008;5(11):1609-14. [DOI: 10.1016/j.hrthm.2008.08.023]
31. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6:e1000100.
33. Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). European Heart Journal 2009;30(21):2631-71.
34. Parry SW, Matthews IG. Implantable loop recorders in the investigation of unexplained syncope: a state of the art review. Heart 2010;96(20):1611-6.
35. Raj SR, Coffin ST. Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension. Progress in Cardiovascular Diseases 2013;55(4):425-33. [DOI: 10.1016/j.pcad.2012.11.004]
36. Williamson C, Reed MJ. Syncope: the emergency department and beyond. Internal and Emergency Medicine 2015;10:843-50.
37. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
38. Romme JJ, Reitsma JB, Black CN, Colman N, Scholten RJ, Wieling W, et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD004194.pub3]
39. Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Rajeswaran A, Metzger JT, et al. Prospective evaluation of patients with syncope: a population-based study. American Journal of Medicine 2001;111(3):177-84.
40. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
41. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
42. Serletis A, Rose S, Sheldon AG, Sheldon RS. Vasovagal syncope in medical students and their first-degree relatives. European Heart Journal 2006;27(16):1965-70.
43. Sheldon RS, Morillo CA, Krahn AD, O'Neill B, Thiruganasambandamoorthy V, Parkash R, et al. Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society Position Paper. Canadian Journal of Cardiology 2011;27:246-53.
44. Shen WK, Decker WW, Smars PA, Goyal DG, Walker AE, Hodge DO, et al. Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation 2004;110(24):3636-45.
45. Solbiati M, Sheldon RS. Implantable rhythm devices in the management of vasovagal syncope. Autonomic Neuroscience: Basic & Clinical 2014;184:33-9. [DOI: 10.1016/j.autneu.2014.05.012]
46. Solbiati M, Casazza G, Dipaola F, Rusconi AM, Cernuschi G, Barbic F, et al. Syncope recurrence and mortality: a systematic review. Europace 2015;17:300-8.
47. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, et al. Incidence and prognosis of syncope. New England Journal of Medicine 2002;347(12):878-85.
48. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Date accessed: 1 Feb 2016.
49. Sun BC. Quality-of-life, health service use, and costs associated with syncope. Progress in Cardiovascular Diseases 2013;55(4):370-5.
50. Solbiati M, Costantino G, Casazza G, Dipaola F, Galli A, Furlan R, et al. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD011637]